Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company Announces Selection of Therapeutic Targets for Immuno-Oncology Program
Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio [...]
Voltron Therapeutics, Inc.’s Scientific Co-Founder Dr. Mark C. Poznansky has Guest Essay Published in the New York Times
Voltron Therapeutics, Inc.’s Scientific Co-Founder Dr. Mark C. [...]
Voltron Therapeutics, Inc. Announces Positive Data from Animal Testing of Self-Assembling Vaccine in the Fight Against COVID-19
Voltron Therapeutics, Inc. Announces Positive Data from Animal [...]
Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. Names Anthony Zook, Former CEO of AstraZeneca North America, Executive Chairman.
Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. [...]
Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge Perspectives on the Latest Developments in COVID-19 Vaccine Development Strategy”
Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge [...]
Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19
Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling [...]
Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore Strategic Alternatives for its HaloVax™ Subsidiary
Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore [...]
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer VaccineVoltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement [...]
Voltron Therapeutics Publishes Letter to Shareholders
Voltron Therapeutics Publishes Letter to Shareholders
Dr. Poznansky is interviewed on Bloomberg Radio
Listen to Dr. Poznanski's interview on Bloomberg Radio and his thoughts on operation "Warp Speed"